Low-dose tamoxifen triggers side effects even in healthy women

A six-armed clinical trial reveals that tamoxifen—a widely prescribed breast cancer preventive—causes measurable adverse effects at lower doses than typically studied. The findings could reshape how physicians weigh prevention benefits against patient tolerance, affecting treatment decisions for millions of women at risk.

Originaltitel: Side effects of low-dose tamoxifen: results from a six-armed randomised controlled trial in healthy women